CMPXVSGTBP• 6 Months (Normalized)
CMPX vs GTBP (Compass Therapeutics Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Apr 1 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMPX Performance $1.17
-78.45%
Compass Therapeutics Inc.
Normalized Baseline0.00%
GTBP Performance $7.1
+1635.94%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1714.39 pts
GTBP outperforming by 1714.39 percentage points
CMPXGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMPX GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(121 dates)
| Date | CMPX Price | CMPX Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $1.17 | -78.45% | $7.10 | +1635.94% | -1714.39% |
| Sep 22, 2026 | $1.24 | -77.16% | $- | - | |
| Sep 21, 2026 | $1.82 | -66.48% | $7.18 | +1655.50% | -1721.98% |
| Sep 18, 2026 | $1.90 | -65.01% | $7.16 | +1650.61% | -1715.62% |
| Sep 17, 2026 | $1.85 | -65.93% | $7.49 | +1731.30% | -1797.23% |
| Sep 16, 2026 | $1.83 | -66.30% | $7.81 | +1809.54% | -1875.84% |
| Sep 15, 2026 | $1.85 | -65.93% | $9.00 | +2100.49% | -2166.42% |
| Sep 14, 2026 | $1.96 | -63.90% | $11.63 | +2743.52% | -2807.42% |
| Sep 11, 2026 | $2.00 | -63.17% | $8.61 | +2005.13% | -2068.30% |
| Sep 10, 2026 | $2.05 | -62.25% | $6.18 | +1411.00% | -1473.25% |
| Sep 09, 2026 | $2.18 | -59.85% | $5.98 | +1362.10% | -1421.95% |
| Sep 08, 2026 | $2.21 | -59.30% | $- | - | |
| Sep 04, 2026 | $2.38 | -56.17% | $0.24 | -41.08% | -15.09% |
| Sep 03, 2026 | $2.37 | -56.35% | $0.25 | -38.39% | -17.96% |
| Sep 02, 2026 | $2.43 | -55.25% | $0.28 | -30.81% | -24.44% |
Page 1 of 9